|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun M, Richards S, Prasad DV, Mai XM,
Rudensky A and Dong C: Characterization of mouse and human B7-H3
genes. J Immunol. 168:6294–6297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ingebrigtsen VA, Boye K, Nesland JM,
Nesbakken A, Flatmark K and Fodstad Ø: B7-H3 expression in
colorectal cancer: Associations with clinicopathological parameters
and patient outcome. BMC Cancer. 14:6022014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bin Z, Guangbo Z, Yan G, Huan Z, Desheng L
and Xueguang Z: Overexpression of B7-H3 in CD133+
colorectal cancer cells is associated with cancer progression and
survival in human patients. J Surg Res. 188:396–403. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu Y, Lv X, Wu Y, Xu J, Wang L, Chen W,
Zhang W, Li J, Zhang S and Qiu H: Expression of costimulatory
molecule B7-H3 and its prognostic implications in human acute
leukemia. Hematology. 20:187–195. 2015. View Article : Google Scholar
|
|
6
|
Baral A, Ye HX, Jiang PC, Yao Y and Mao Y:
B7-H3 and B7-H1 expression in cerebral spinal fluid and tumor
tissue correlates with the malignancy grade of glioma patients.
Oncol Lett. 8:1195–1201. 2014.PubMed/NCBI
|
|
7
|
Wang F, Wang G, Liu T, Yu G, Zhang G and
Luan X: B7-H3 was highly expressed in human primary hepatocellular
carcinoma and promoted tumor progression. Cancer Invest.
32:262–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun J, Mao Y, Zhang YQ, Guo YD, Mu CY, Fu
FQ and Zhang XG: Clinical significance of the induction of
macrophage differentiation by the costimulatory molecule B7-H3 in
human non-small cell lung cancer. Oncol Lett. 6:1253–1260.
2013.PubMed/NCBI
|
|
9
|
Maeda N, Yoshimura K, Yamamoto S, Kuramasu
A, Inoue M, Suzuki N, Watanabe Y, Maeda Y, Kamei R, Tsunedomi R, et
al: Expression of B7-H3, a potential factor of tumor immune evasion
in combination with the number of regulatory T cells, affects
against recurrence-free survival in breast cancer patients. Ann
Surg Oncol. 21(Suppl 4): S546–S554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roth TJ, Sheinin Y, Lohse CM, Kuntz SM,
Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML,
et al: B7-H3 ligand expression by prostate cancer: A novel marker
of prognosis and potential target for therapy. Cancer Res.
67:7893–7900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Bai Y, Cui W, Wang Z, Zhang G, Xu
Y, Zhu X, Li Y and Wang JH: Effects of B7-H3 on the inflammatory
response and expression of MMP-9 in mice with pneumococcal
meningitis. J Mol Neurosci. 50:146–153. 2013. View Article : Google Scholar
|
|
12
|
Wang J, Chong KK, Nakamura Y, Nguyen L,
Huang SK, Kuo C, Zhang W, Yu H, Morton DL and Hoon DS: Hoon = B7-H3
associated with tumor progression and epigenetic regulatory
activity in cutaneous melanoma. J Invest Dermatol. 133:2050–2058.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao X, Li DC, Zhu XG, Gan WJ, Li Z, Xiong
F, Zhang ZX, Zhang GB, Zhang XG and Zhao H: B7-H3 overexpression in
pancreatic cancer promotes tumor progression. Int J Mol Med.
31:283–291. 2013.
|
|
14
|
Ingebrigtsen VA, Boye K, Tekle C, Nesland
JM, Flatmark K and Fodstad O: B7-H3 expression in colorectal
cancer: Nuclear localization strongly predicts poor outcome in
colon cancer. Int J Cancer. 131:2528–2536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Artacho-Cordón F, Ríos-Arrabal S, Lara PC,
Artacho-Cordón A, Calvente I and Nńñez MI: Matrix
metalloproteinases: Potential therapy to prevent the development of
second malignancies after breast radiotherapy. Surg Oncol.
21:e143–e151. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC,
Jin J and Chang C: Infiltrating T cells promote prostate cancer
metastasis via modulation of FGF11 >miRNA-541> androgen
receptor (AR) >MMP9 signaling. Mol Oncol. 9:44–57. 2015.
View Article : Google Scholar
|
|
17
|
Jian H, Zhao Y, Liu B and Lu S: SEMA4b
inhibits MMP9 to prevent metastasis of non-small cell lung cancer.
Tumour Biol. 35:11051–11056. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jang SY, Kim A, Kim JK, Kim C, Cho YH, Kim
JH, Kim CH and Lee JY: Metformin inhibits tumor cell migration via
down-regulation of MMP9 in tamoxifen-resistant breast cancer cells.
Anticancer Res. 34:4127–4134. 2014.PubMed/NCBI
|
|
19
|
Zhou DN, Deng YF, Li RH, Yin P and Ye CS:
Concurrent alterations of RAGE, RECK and MMP9 protein expression
are relevant to Epstein-Barr virus infection, metastasis and
survival in nasopharyngeal carcinoma. Int J Clin Exp Pathol.
7:3245–3254. 2014.
|
|
20
|
Huang Q, Lan F, Wang X, Yu Y, Ouyang X,
Zheng F, Han J, Lin Y, Xie Y, Xie F, et al: IL-1β-induced
activation of p38 promotes metastasis in gastric adenocarcinoma via
upregulation of AP-1/c-fos, MMP2 and MMP9. Mol Cancer. 13:182014.
View Article : Google Scholar
|
|
21
|
Li L, Tan J, Zhang Y, Han N, Di X, Xiao T,
Cheng S, Gao Y and Liu Y: DLK1 promotes lung cancer cell invasion
through upregulation of MMP9 expression depending on Notch
signaling. PLoS One. 9:e915092014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han S, Han L, Yao Y, Sun H, Zan X and Liu
Q: Activated hepatic stellate cells promote hepatocellular
carcinoma cell migration and invasion via the activation of
FAK-MMP9 signaling. Oncol Rep. 31:641–648. 2014.
|
|
23
|
Feng X, Miao G, Han Y and Xu Y: CARMA3 is
overexpressed in human glioma and promotes cell invasion through
MMP9 regulation in A172 cell line. Tumour Biol. 35:149–154. 2014.
View Article : Google Scholar
|
|
24
|
Song H, Tian Z, Qin Y, Yao G, Fu S and
Geng J: Astrocyte elevated gene-1 activates MMP9 to increase
invasiveness of colorectal cancer. Tumour Biol. 35:6679–6685. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim HC, Kim YS, Oh HW, Kim K, Oh SS, Kim
JT, Kim BY, Lee SJ, Choe YK, Kim DH, et al: Collagen triple helix
repeat containing 1 (CTHRC1) acts via ERK-dependent induction of
MMP9 to promote invasion of colorectal cancer cells. Oncotarget.
5:519–529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei SC, Tsao PN, Weng MT, Cao Z and Wong
JM: Flt-1 in colorectal cancer cells is required for the tumor
invasive effect of placental growth factor through a p38-MMP9
pathway. J Biomed Sci. 20:392013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kale S, Raja R, Thorat D, Soundararajan G,
Patil TV and Kundu GC: Osteopontin signaling upregulates
cyclooxy-genase-2 expression in tumor-associated macrophages
leading to enhanced angiogenesis and melanoma growth via α9β1
integrin. Oncogene. 33:2295–2306. 2014. View Article : Google Scholar
|
|
28
|
Rangaswami H, Bulbule A and Kundu GC:
Nuclear factor-inducing kinase plays a crucial role in
osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear
factor kappaB-mediated promatrix metalloproteinase-9 activation. J
Biol Chem. 279:38921–38935. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du W, Hong J, Wang YC, Zhang YJ, Wang P,
Su WY, Lin YW, Lu R, Zou WP, Xiong H and Fang JY: Inhibition of
JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via
mitochondrial pathway. J Cell Mol Med. 16:1878–1888. 2012.
View Article : Google Scholar
|
|
30
|
Xiong H, Chen ZF, Liang QC, Du W, Chen HM,
Su WY, Chen GQ, Han ZG and Fang JY: Inhibition of DNA
methyl-transferase induces G2 cell cycle arrest and apoptosis in
human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5
signalling. J Cell Mol Med. 13:3668–3679. 2009. View Article : Google Scholar
|
|
31
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,
2/STAT3 signaling induces apoptosis, cell cycle arrest and reduces
tumor cell invasion in colorectal cancer cells. Neoplasia.
10:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang T, Jiang B, Zou ST, Liu F and Hua D:
Overexpression of B7-H3 augments anti-apoptosis of colorectal
cancer cells by Jak2-STAT3. World J Gastroenterol. 21:1804–1813.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Curran S and Murray GI: Matrix
metalloproteinases: Molecular aspects of their roles in tumour
invasion and metastasis. Eur J Cancer. 36:1621–1630. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tekle C, Nygren MK, Chen YW, Dybsjord I,
Nesland JM, Maelandsmo GM and Fodstad O: B7-H3 contributes to the
metastatic capacity of melanoma cells by modulation of known
metastasis-associated genes. Int J Cancer. 130:2282–2290. 2012.
View Article : Google Scholar
|
|
37
|
Zhang X, Yin P, Di D, Luo G, Zheng L, Wei
J, Zhang J, Shi Y, Zhang J and Xu N: IL-6 regulates MMP-10
expression via JAK2/STAT3 signaling pathway in a human lung
adenocar-cinoma cell line. Anticancer Res. 29:4497–4501.
2009.PubMed/NCBI
|
|
38
|
Senft C, Priester M, Polacin M, Schröder
K, Seifert V, Kögel D and Weissenberger J: Inhibition of the
JAK-2/STAT3 signaling pathway impedes the migratory and invasive
potential of human glioblastoma cells. J Neurooncol. 101:393–403.
2011. View Article : Google Scholar
|
|
39
|
Reis ST, Pontes-Junior J, Antunes AA,
Dall'Oglio MF, Dip N, Passerotti CC, Rossini GA, Morais DR,
Nesrallah AJ, Piantino C, et al: miR-21 may acts as an oncomir by
targeting RECK, a matrix metalloproteinase regulator, in prostate
cancer. BMC Urol. 12:142012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu H, Tekle C, Chen YW, Kristian A, Zhao
Y, Zhou M, Liu Z, Ding Y, Wang B, Mælandsmo GM, et al: B7-H3
silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3
phosphorylation. Mol Cancer Ther. 10:960–971. 2011. View Article : Google Scholar : PubMed/NCBI
|
